These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 11490019)
1. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. Soane L; Cho HJ; Niculescu F; Rus H; Shin ML J Immunol; 2001 Aug; 167(4):2305-11. PubMed ID: 11490019 [TBL] [Abstract][Full Text] [Related]
2. Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD. Hila S; Soane L; Koski CL Glia; 2001 Oct; 36(1):58-67. PubMed ID: 11571784 [TBL] [Abstract][Full Text] [Related]
3. C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP. Cudrici C; Niculescu F; Jensen T; Zafranskaia E; Fosbrink M; Rus V; Shin ML; Rus H J Immunol; 2006 Mar; 176(5):3173-80. PubMed ID: 16493077 [TBL] [Abstract][Full Text] [Related]
4. Role of the C5b-9 complement complex in cell cycle and apoptosis. Rus HG; Niculescu FI; Shin ML Immunol Rev; 2001 Apr; 180():49-55. PubMed ID: 11414362 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. Soane L; Rus H; Niculescu F; Shin ML J Immunol; 1999 Dec; 163(11):6132-8. PubMed ID: 10570303 [TBL] [Abstract][Full Text] [Related]
6. cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release. Webster CR; Usechak P; Anwer MS Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G727-38. PubMed ID: 12181189 [TBL] [Abstract][Full Text] [Related]
7. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Negoro S; Oh H; Tone E; Kunisada K; Fujio Y; Walsh K; Kishimoto T; Yamauchi-Takihara K Circulation; 2001 Jan; 103(4):555-61. PubMed ID: 11157722 [TBL] [Abstract][Full Text] [Related]
8. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad. Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242 [TBL] [Abstract][Full Text] [Related]
9. Bcl-xL mediates a survival mechanism independent of the phosphoinositide 3-kinase/Akt pathway in prostate cancer cells. Yang CC; Lin HP; Chen CS; Yang YT; Tseng PH; Rangnekar VM; Chen CS J Biol Chem; 2003 Jul; 278(28):25872-8. PubMed ID: 12738789 [TBL] [Abstract][Full Text] [Related]
11. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Uchiyama T; Engelman RM; Maulik N; Das DK Circulation; 2004 Jun; 109(24):3042-9. PubMed ID: 15184284 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. del Peso L; González-García M; Page C; Herrera R; Nuñez G Science; 1997 Oct; 278(5338):687-9. PubMed ID: 9381178 [TBL] [Abstract][Full Text] [Related]
13. PI3K inhibition in neonatal rat brain slices during and after hypoxia reduces phospho-Akt and increases cytosolic cytochrome c and apoptosis. Hirai K; Hayashi T; Chan PH; Zeng J; Yang GY; Basus VJ; James TL; Litt L Brain Res Mol Brain Res; 2004 Apr; 124(1):51-61. PubMed ID: 15093685 [TBL] [Abstract][Full Text] [Related]
14. Serum bioactive lysophospholipids prevent TRAIL-induced apoptosis via PI3K/Akt-dependent cFLIP expression and Bad phosphorylation. Kang YC; Kim KM; Lee KS; Namkoong S; Lee SJ; Han JA; Jeoung D; Ha KS; Kwon YG; Kim YM Cell Death Differ; 2004 Dec; 11(12):1287-98. PubMed ID: 15297884 [TBL] [Abstract][Full Text] [Related]
15. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Kennedy SG; Kandel ES; Cross TK; Hay N Mol Cell Biol; 1999 Aug; 19(8):5800-10. PubMed ID: 10409766 [TBL] [Abstract][Full Text] [Related]
16. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
17. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. Hatano E; Brenner DA Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1357-68. PubMed ID: 11705740 [TBL] [Abstract][Full Text] [Related]
19. Activation of PI3-kinase/PKB contributes to delay in neutrophil apoptosis after thermal injury. Hu Z; Sayeed MM Am J Physiol Cell Physiol; 2005 May; 288(5):C1171-8. PubMed ID: 15625305 [TBL] [Abstract][Full Text] [Related]
20. Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance. Thakkar H; Chen X; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK J Biol Chem; 2001 Oct; 276(42):38361-9. PubMed ID: 11461904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]